These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 12810107)

  • 1. What's the difference between CD80 and CD86?
    Sansom DM; Manzotti CN; Zheng Y
    Trends Immunol; 2003 Jun; 24(6):314-9. PubMed ID: 12810107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.
    Vandenborre K; Van Gool SW; Kasran A; Ceuppens JL; Boogaerts MA; Vandenberghe P
    Immunology; 1999 Nov; 98(3):413-21. PubMed ID: 10583602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins.
    van Wijk F; Nierkens S; de Jong W; Wehrens EJ; Boon L; van Kooten P; Knippels LM; Pieters R
    J Immunol; 2007 Jun; 178(11):6894-900. PubMed ID: 17513738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B7-CTLA4 interaction enhances both production of antitumor cytotoxic T lymphocytes and resistance to tumor challenge.
    Zheng P; Wu Y; Guo Y; Lee C; Liu Y
    Proc Natl Acad Sci U S A; 1998 May; 95(11):6284-9. PubMed ID: 9600957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple negative feedbacks on CD152 expression in allograft tolerance.
    Tsai MK; Ho HN; Chien HF; Tzeng MC; Chen CH; Lee PH
    Transplantation; 2005 Jan; 79(2):174-81. PubMed ID: 15665765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of costimulatory CD80/CD86-CD28/CD152 molecules in nasal mucosa of patients with perennial allergic rhinitis.
    Hattori H; Okano M; Yoshino T; Akagi T; Nakayama E; Saito C; Satoskar AR; Ogawa T; Azuma M; Nishizaki K
    Clin Exp Allergy; 2001 Aug; 31(8):1242-9. PubMed ID: 11529894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expanding world of co-stimulation: the two-signal model revisited.
    Chambers CA
    Trends Immunol; 2001 Apr; 22(4):217-23. PubMed ID: 11274928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.
    Linsley PS; Greene JL; Brady W; Bajorath J; Ledbetter JA; Peach R
    Immunity; 1994 Dec; 1(9):793-801. PubMed ID: 7534620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant.
    Minguela A; Marín L; Torío A; Muro M; García-Alonso AM; Moya-Quiles MR; Sánchez-Bueno F; Parrilla P; Alvarez-López MR
    Hum Immunol; 2000 Jul; 61(7):658-69. PubMed ID: 10880736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD80 binding polyproline helical peptide inhibits T cell activation.
    Srinivasan M; Lu D; Eri R; Brand DD; Haque A; Blum JS
    J Biol Chem; 2005 Mar; 280(11):10149-55. PubMed ID: 15598660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of self-tolerance by CD80/CD86 interactions.
    Lu P; Wang YL; Linsley PS
    Curr Opin Immunol; 1997 Dec; 9(6):858-62. PubMed ID: 9492990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease.
    Chang TT; Kuchroo VK; Sharpe AH
    Curr Dir Autoimmun; 2002; 5():113-30. PubMed ID: 11826754
    [No Abstract]   [Full Text] [Related]  

  • 13. Interference with CD28, CD80, CD86 or CD152 in collagen-induced arthritis. Limited role of IFN-gamma in anti-B7-mediated suppression of disease.
    Tellander AC; Pettersson U; Runström A; Andersson M; Michaëlsson E
    J Autoimmun; 2001 Aug; 17(1):39-50. PubMed ID: 11488636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD152 ligation by CD80 on T cells is required for the induction of unresponsiveness by costimulation-deficient antigen presentation.
    Chai JG; Vendetti S; Amofah E; Dyson J; Lechler R
    J Immunol; 2000 Sep; 165(6):3037-42. PubMed ID: 10975813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
    Broeren CP; Gray GS; Carreno BM; June CH
    J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation and the CD28/CTLA4/B7 pathway.
    Alegre M; Fallarino F; Zhou P; Frauwirth K; Thistlethwaite J; Newell K; Gajewski T; Bluestone J
    Transplant Proc; 2001; 33(1-2):209-11. PubMed ID: 11266782
    [No Abstract]   [Full Text] [Related]  

  • 17. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
    Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
    Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of protein-protein interfaces implicated in CD80-CD28 costimulatory signaling.
    Sørensen P; Kussmann M; Rosén A; Bennett KL; Thrige Dda G; Uvebrant K; Walse B; Roepstorff P; Björk P
    J Immunol; 2004 Jun; 172(11):6803-9. PubMed ID: 15153498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD80 expression is induced on activated B cells following stimulation by CD86.
    Sahoo NC; Rao KV; Natarajan K
    Scand J Immunol; 2002 Jun; 55(6):577-84. PubMed ID: 12028560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A crucial role of host CD80 and CD86 in rat cardiac xenograft rejection in mice.
    Kano M; Bashuda H; Yagita H; Okumura K; Morishita Y
    Transplantation; 1998 Mar; 65(6):837-43. PubMed ID: 9539097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.